[Influence of plasma viscosity changes after osmo-and oncotherapy on the hemodynamics].
D001809:Blood Viscosity / Q000187:drug effects; D001810:Blood Volume / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002306:Cardiac Volume / Q000187:drug effects; D003911:Dextrans / Q000494:pharmacology; D006400:Hematocrit; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D008970:Molecular Weight; D009994:Osmolar Concentration; D010100:Oxygen / Q000097:blood; D010101:Oxygen Consumption; D010952:Plasma Substitutes / Q000494:pharmacology*; D010953:Plasma Volume / Q000187:drug effects; D012996:Solutions; D013012:Sorbitol / Q000494:pharmacology
D003911:Dextrans; D010952:Plasma Substitutes; D012996:Solutions; D013012:Sorbitol; D010100:Oxygen
Einfluss der Plasmaviscositätsänderung nach Osmo- und Onkotherapie auf die Hämodynamik.